Top Markets
Coin of the day
Handa Pharmaceuticals, Inc. Handa Pharmaceuticals, Inc.

Handa Pharmaceuticals, Inc.

6620
Κατάταξη σε μετοχές #13384
Handa Pharmaceuticals, Inc. operates as a specialized drug company,... Handa Pharmaceuticals, Inc. operates as a specialized drug company, concentrating its efforts on creating and advancing new medications for diverse health issues across both the United States and China. The firm currently offers Quetiapine XR, a treatment for Schizophrenia, as well as Dexlansoprazole DR capsules. Beyond its existing portfolio, Handa is actively cultivating a robust pipeline of therapies. This includes their cutting-edge ONCORE drug delivery platform, engineered to boost patient adherence and improve the safety of tyrosine kinase inhibitor oncology drugs. Other significant projects encompass a 505(b)(2)NDA therapeutic agent, Tascenso ODT for managing multiple sclerosis, and the oncology candidates HND-033 and HND-027. Furthermore, the company's development initiatives feature HND-004, designed for diabetic patients; HND-032, intended to aid in smoking cessation; and HND-026, a gastrointestinal medication. Founded in 2014, Handa Pharmaceuticals, Inc. has its main corporate headquarters situated in Tainan City, Taiwan.
Τιμή μετοχής
$2.95
Κεφαλαιοποίηση
$491.95M
Αλλαγή (1 ημέρα)
9.94%
Αλλαγή (1 έτος)
8.06%
Χώρα
TW
Εμπόριο Handa Pharmaceuticals, Inc. (6620)

Κατηγορία

Ιστορικό τιμής μετοχής για την Handa Pharmaceuticals, Inc. (6620)
Υψηλότερη τιμή κλεισίματος: $2.50 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $3.07 στις 2016-12-01
Ιστορικό τιμής μετοχής της Handa Pharmaceuticals, Inc. από 2016 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) -6.68%
2025 76.45%
2024 -69.59%
2023 78.09%
2022 89.09%
2021 96.39%
2020 3.11%
2019 -3.91%
2018 -21.54%
2017 -62.75%
2016 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$171.67 -
DE
$164.88 30.29%
DE
$37.61 25.11%
JP
$21.90 21.12%
IN
$218.36 25.22%
CH